Publication
Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
Pedro Cahn, Anton L Pozniak, Horacio Mingrone, Andrey Shuldyakov, Carlos Brites, Jaime F Andrade-Villanueva, Gary Richmond, Carlos Beltran Buendia, Jan Fourie, Moti Ramgopal, Debbie Hagins, Franco Felizarta, Jose Madruga, Tania Reuter, Tamara Newman, Catherine B Small, John Lombaard, Beatriz Grinsztejn, David Dorey, Mark Underwood, Sandy Griffith, Sherene Min
The Lancet, August 2013, Elsevier
DOI: 10.1016/s0140-6736(13)61221-0